The FTC has reportedly called on “Pharma Bro” Martin Shkreli to be held in contempt of court for allegedly disobeying terms of a recent investigation into his business dealings.
NBC reports that Martin Shkreli, also known as “Pharma Bro,” has come under fire from the FTC for allegedly disobeying the terms of a recent investigation by the agency into his business dealings and failing to pay a $64.6 million fine he owed for prior wrongdoings. The FTC has asked a federal court to hold Shkreli in contempt.
Shkreli was found guilty of securities fraud for mismanaging two investment funds in 2017. He gained notoriety for raising the cost of the life-saving drug Daraprim by 4,000% while serving as the head of Turing Pharmaceuticals. Numerous publications dubbed him “the most hated man in America” as a result of his actions.
In 2022, as part of a different FTC antitrust…
